Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

SFM Final > SFM Quiz 2 > Flashcards

SFM Quiz 2 Flashcards

1
Q

the storage site of lysosomal hydrolases No digestive events Homogenous Inactive enzymes

A

primary lysosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

engaged in a catalytic process digestive enzymes heterogenous active enzymes

A

secondary lysosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cholesterol uptake disrupted Characterized by elevation of LDL, the predominant cholesterol transport protein in the plasma

A

familial hypercholesteremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

absence or reduced number of peroxisomes congenital

A

Zellweger spectrum disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Binds to 30S subunit and interferes with the binding of fmet-tRNA and impairs initiation. Interferes with 30S subunit association with 50S subunit.

A

Streptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

binds to large 50S subunit, blocking translocation of the ribosome.

A

Clindamycin, Erythromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

binds to small 30S subunit, blocks entry of aminoacyl-tRNA to ribosomal complex and impairs elongation.

A

Tetracycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inhibits peptidyl transferase activity and impairs peptide bond formation.

A

Chloramphenicol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

binds to large 60S subunit (euk.), blocking entry of aminoacyl-tRNA to ribosomal complex.

A

Shiga toxin, Ricin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

inactivates GTP-bound EF-2, interfering with ribosomal translocation (euk.)

A

Diptheria toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

inhibits peptidyl transferase (euk.) and impairs peptide bond formation.

A

Cycloheximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

causes premature chain termination (prok/euk). Resembles the 3’ end of the aminoacylated-tRNA. Enters the A site and adds to the growing chain. Forms a puromycylated chain, leading to premature chain release. More resistant to hydrolysis. Stops the ribosome from functioning.

A

Puromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

does not change the amino acid.

A

silent mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

changes amino acid in the protein with either no effect on protein function or a protein with vastly different function.

A

missense mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

codon changes into a stop codon causing premature chain termination. Also called null mutation. Protein either degraded or formed as a truncated version.

A

nonsense mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

one or more nucleotides are deleted or inserted into ORF. Out of frame causes change in the codon sequence and consequently alteration in the amino acid sequence of the protein (E.g., Duchenne Muscular Dystrophy, beta thalassemia)

A

frameshift mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Arises from a missense mutation of 6th codon in the allele of the gene for human β-globin (HBB),

A

Sickle cell anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sickle cell anemia initial amino acid: Sickle cell anemia altered amino acid:

A

Glutamic acid Valine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

out-of-frame (OOF) deletion to the dystrophin gene leads to partially or non-functioning dystrophin protein. leads to muscle wasting

A

Duchenne Muscular Dystrophy (DMD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In-frame deletions result in expression of truncated forms of dystrophin, giving rise to a milder form of the disease

A

Becker muscular dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Translocation signal: cytoplasm

A

None

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Translocation signal: Mitochondria

A

N-terminal hydrophobic alpha-helix HSP-70= chaperone through TOM->TIM->matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Translocation signal: Nucleus

A

KKKRK signal Nuclear pores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Translocation signal: Peroxisome

A

C-terminal SKL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Translocation signal: ER lumen

A

C-terminal KDEL SRP wraps around ribosome-mRNA-peptide complex=stop translation Luminal enzymes cleave signal=released

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Translocation signal: Lysosome

A

M-6-P (I-cell disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Translocation signal: secretion

A

tryptophan rich-domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Translocation signal: membrane

A

N-terminal apolar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Tagging of lysosomal proteins with mannose 6P is defective. Proteins not targeted to lysosomes. High plasma levels of lysosomal enzymes. By 6 months: failure to thrive and developmental delays and physical manifestations. Development delays of motor skills more pronounced than cognitive delays. Abnormal skeletal development, coarse facial features, restricted joint movement, stiff claw-shaped hands, short-trunk dwarfism, clouding on the cornea. Hepatomegaly, splenomegaly, defective heart valves. Recurrent respiratory tract infections: (pneumonia, otitis media bronchitis). Death frequently occurs by age 7, usually due to congestive heart failure or recurrent respiratory tract infections.

A

I-cell disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

O-link glycosylation

A

hydroxyl group: Serine, Threonine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

N-link glycosylation

A

Asparagine Transferred from phospho Dolichol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Formation of an ester bond between phosphate and OH of an amino acid.

A

Phosphorylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Formation and reorganization of these bonds occur in ER lumen.

A

Disulfide bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Lysines in collagen modified to form 5-hydroxylysines, further glycosylated with addition of glucose and galactose. Some lysines deaminated to aldehydes Some prolines hydroxylated to hydroxyprolines. Modifications important for assembly of collagen What vitamin is mandatory for lysyl and prolyl hydroxylases?

A

vitamin A Ascorbic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

overly flexible joints, walls of blood vessels, intestines or uterus may rupture

A

Ehlers-Danlos syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

blisters on skin

A

Epidermolysis Bullosa Simplex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Amyloid precursor protein (APP) breaks down to form amyloid beta peptide (Aβ). Misfolding/Aggregation of Aβ forms plaques in brain (extracellular). Hyperphosphorylation of Tau (neurofibrillary tangles) (intracellular).

A

Alzheimer’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Aggregation of α-synuclein (AS) protein forms insoluble fibrils which deposit as Lewy bodies in dopaminergic neurons in substantia nigra. Results in selective death of these neurons. Symptoms due to reduced availability of dopamine.

A

Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Mutation in Huntingtin gene results in expansion of CAG triplet repeats. Results in Polyglutamine repeats in abnormal Huntingtin protein. Forms intramolecular H-bonds, which eventually misfold and aggregate. Selective death of cells in basal ganglia cause the symptoms.

A

Huntington’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Caused by misfolding of prion proteins. Transmissible – infection by misfolded proteins converts normal proteins to misfolded form. Belongs to Transmissible spongiform encephalopathies (TSEs). Spongiform - appearance of infected brains, filled with holes and resemble sponges under a microscope.

A

Creutzfeldt-Jakob disease (HD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Autosomal Dominant Inheritance

A

Postaxial polydactyly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Autosomal Recessive Inheritance

A

Tyrosinase-negative Albinism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

X-linked recessive inheritance

A

Duchenne Muscular Dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Degeneration of retinal ganglion cells Caused by one of three pathogenic mtDNA point mutations affecting NADH dehydrogenase Starves RGCs of energy, making them unable to transmit signals to the brain. Acute or subacute loss of central vision Typically early teens or 20’s Inter-eye delay of 8 weeks

A

Leber’s hereditary optic neuropathy (LHON)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Caused by a mutation in the gene encoding for tRNA for lysine, which disrupts the synthesis of cytochrome-c oxidase Patients present with myoclonus dinated muscle movement (ataxia) and seizures Particularly affects the muscles and nerves Large variability of presentation due to heteroplasmy

A

Myoclonic epilepsy and ragged red fibers (MERRF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Most common maternally-inherited mitochondrial disease Affects many body systems, particularly brain nervous system, and muscles Stroke and dementia Diabetes, deafness, cognitive impairment, short stature, migraine

A

Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

X-linked dominant inheritance

A

hypophosphatemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

two chromosomes are inherited from the same parent, they will have parent-specific imprinting No gene product

A

Uniparental disomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

For some human genes, one of the alleles is transcriptionally inactive (no mRNA produced) Depending on the parent from whom the allele was received

A

Genomic imprinting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Long arm of two acrocentric chromosomes combined, short arm typically is lost

A

Robertsonian translocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Karyotype: 45, XO Monosomy X Female (no Y) Short stature Ovarian hypofunction/premature ovarian failure Many do not undergo puberty Most are infertile ~30% webbed neck Low hairline on neck CV defects No cognitive defects

A

Turner Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Deletion of a region of chromosome 15 Phenotype depends on if deletion is on paternal or maternal chromosome

A

Prader-Willi and Angelman Syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Short stature, hypotonia, small hands/feet, obesity, mild to moderate intellectual disability, uncontrolled eating

A

Paternal = Prader-Willi Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Severe intellectual disability, seizures, ataxic gait

A

Maternal= Angelman Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Karyotype: 47, XXY Varying presentation Varying degrees of cognitive, social, behavioral, learning difficulties Primary hypogonadism (low T) Small and/or undescended testes Gynecomastia, infertility Tall stature Variability in X numbers can increase symptoms (48, XXXY; 49, XXXXY)

A

Klinefelter syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

(47, XX +21) Most common (1 in 700 pregnancies) Strongly associated with increased maternal age Results most commonly from maternal meiotic nondisjunction (in the ovum) Also due to unbalanced translocation 46, XX der(14:21)(q10;q10)+21 (only 4% occurrences) Varying degrees of cognitive impairment Structural abnormalities: increased nuchal translucency, cardiac defects, duodenal atresia, ventriculomegaly, absent nasal bone, short limbs

A

Trisomy 21 Downs Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

(47, XX +18) 1 out of every 6000 births Often IUGR 95% die in utero <10% of live births survive to 1 year Microencephaly, prominent occiput, malformed and low-set ears, small mouth and jaw, cleft lip/palate, rocker bottom feet, overlapped fingers

A

Trisomy 18 Edwards Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

(47, XX +13) Severe developmental abnormalities 1 out of every 12,500 births Most die before birth Most perinatal death within 1 week (13% of live births survive to 10 y.o.) Heart abnormalities, kidney malformations, CNS dysfunction Microcephaly, malformed ears, closely spaced/absent eyes, clenched hands and polydactyl, cleft lip/palate

A

Trisomy 13 Patau Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

The frequency a gene manifests itself

A

Penetrance Retinoblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Describes the range of phenotypes that vary between individuals with a specific genotype

A

Variable expressivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Patients have café-au-lait spots – pigmented areas the color of coffee with cream Spots differ in number, shape, size and position

A

Neurofibromatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Affects the connective tissue, subsequently many different systems Ectopia lentis, weakened and stretched aorta May lead to an aneurysm and aortic dissection

A

Marfan syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Single disorder, trait, or pattern of traits caused by mutations in genes at different chromosomal loci Only one mutant locus is needed for the phenotype to manifest.

A

Locus Heterogeneity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Brittle-bone disease (7/100,000) Mutations in collagen genes (two loci: chromosome 7 and 17), either mutation exhibits similar phenotypes (varying severity)

A

Osteogenesis Imperfecta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

mating’s are more likely to produce offspring affected by rare autosomal recessive disorders

A

Consanguinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

traits in which variations are thought to be caused by the combined effects of multiple genes when environmental factors cause variation in the trait

A

Polygenic Multifactorial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

For multifactorial diseases that are either present or absent, it is thought that a ____ must be crossed before the disease is expressed

A

threshold of liability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

muscular hypertrophy between stomach and duodenum Leads to vomiting and obstruction Five times more common in males than females Males need less risk genes to show disease; females need more risk genes

A

Pyloric Stenosis:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Ability to give rise to all cells of an organism, including embryonic and extraembryonic tissues (placenta).

A

Totipotency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Ability to give rise to all cells of the embryo and subsequently adult tissues. (embryonic stem cells)

A

Pluripotency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Ability to give rise to different cell types of a given lineage. (adult stem cells)

A

Multipotency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Proportions of body parts are determined early Each tissue has fixed number Programmed to have fixed number of divisions Controlled by short range signals that operate for a few hundred cell diameters Define the size of large final structures

A

founder stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

cells that divide frequently Transit from a cell with stem cell characteristics to a differentiated cell Leave the basal layer and incorporate into the layers above Programmed to have limited number of divisions  finite Part of strategy for growth control Committed

A

Transit Amplifying Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

asymmetric division may create 2 cells, one with stem cell characteristics and another with factors that give it the ability to differentiate

A

Divisional Asymmetry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Division makes 2 identical cells but environment may influence/alter 1 cell

A

Environmental Asymmetry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Some tissues’ stem cells selectively retain original DNA A way to prevent genetic errors in stem cells This daughter cell will retain stem cell characteristics Original strand of DNA preserved in stem cells from generation to generation Second cell gets the newly synthesized strand

A

immortal strand hypothesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Derived from the blastocyst stage of embryo Capable of proliferating indefinitely in culture Unrestricted developmental potential When put back in blastocyst they can integrate well with the embryo Develop into different cell types If injected into an embryo at a later stage or into an adult they fail to receive appropriate sequence of cues for proper differentiation Can become a tumor

A

embryonic stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Transcription factors essential for establishment and maintenance of pluripotent stem cells in the embryo

A

Nanog, Oct4, Sox2 and FoxD3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

required for early stages of pluripotent cell differentiation

A

GCNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

growth factors found in pluripotent cells

A

Cripto and GDF-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

nucleus taken from somatic cell of patient and injected into oocyte of a donor replacing the ooctye nucleus Blastocyst generated from this hybrid oocyte and ES cells isolated

A

Somatic cell nuclear transfer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

4 gene regulatory factors

A

Oct3/4, Sox2, Myc and KIf4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

: signal (hormone) is transported via blood. Example epinephrine Long-distance signaling Epinephrine released by adrenal medulla and acts on heart muscle Long-lasting: half-life on minute scale Freely diffusing signal

A

Endocrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

: signal diffuses to neighboring target cell of a different cell type. Example testosterone Leydig cells synthesize and secrete testosterone which induces spermatogenesis by acting on Sertoli and germ cells Local signaling Short-lived signal

A

Paracrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

secreting cells express surface receptors for the signal. Example interleukin-1 Or release to cells of the same type Common in chemokines: interleukin-1 produced by T-lymphocytes promote their own replication during an immune response Action of Growth Factors in cancer cells

A

Autocrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

signal binds to signaling cell which then binds to receptor on the target cell. Example heparin-binding epidermal growth factor Heparin-binding epidermal growth factor-like growth factor (HB-EGF) binds to EGF receptor In immune cells

A

Direct/Juxtacrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Drop in Hormone levels: -decreased adenylyl cyclase activity - decreased cAMP - decreased PKA activity Remove the signaling molecule: phosphodiesterase will remove cAMP/cGMP Receptor sequestration: endosome Receptor destruction: endosomes + lysosomes (proteases)

A

Signal desensitization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q
  1. Signal molecule
  2. GPCR
  3. PLC-> PIP3-> IP3 (Ca+2 channel and PKC) + DAG (PKC=phosphorylation of proteins)
  4. Ca+2-calmodulin complex=activation of proteins (ex. CAM kinase, MLC kinase)
A

Gq-phospholipase C ex. Acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q
  1. Light 2. GPCR 3. cGMP PDE: cGMP-> 5’-GMP
A

Gt-cGMP phosphodiesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q
  1. Signal molecule 2. GPCR 3. AC: ATP->cAMP (inactive->active PKA=phosphorylates proteins) 4. PDE: cAMP->AMP
A

Gs- stimulate adenylate cyclase ex. Epinephrine (beta), Histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q
  1. Signal molecule 2. GPCR 3. GTPGialpha=no AC cAMP production
A

Gi- inhibits adenylate cyclase ex. Epinephrine/Norepinephrine (alpha), Dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Inhibitors of cGMP PDE

A

increase cGMP=Viagra increase cAMP=caffeine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Covalent modification of α subunits of Gs ADP ribosylation of Arg in Gs α decreases intrinsic GTPase activity Gsα remains active (GTP bound form) and continuously stimulates adenylate cyclase, resulting in overproduction of cAMP

A

Cholera toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

prevents the activation of GiαADP ribosylation of Cys on Giα prevents activation and dissociation of α subunit from the trimeric G protein complex Less inhibition of AC and hence overproduction of cAMP

A

Pertussis toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

diffuses to neighboring muscle and activates guanylate cyclase, leading to the production of cGMP. cGMP produced from activated guanylate cyclase results in smooth muscle relaxation and vasodilation. Nitroglycerine and other nitrates (the medicines taken by patients with angina) decompose to form NO and help to lower blood pressure.

A

Nitric oxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

lipophilic compounds that block the effects of histamine to the H1 GPCR

A

antihistamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

condition marked by growth of tumors in nerve tissue. Caused by inactivating mutation in ____ gene, ___ uncontrollably activated pathways for nerve tissue growth. Optical glioma, macrocephaly, learning disabilities

A

Neurofibromatosis GAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

breast cancer drug ___ targets HER2, which belongs to the family of EGF-binding ___

A

Herceptin RTKs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

both probe and target nucleic acid are DNA probe is single stranded DNA and target is mRNA

A

Southern Blotting Northern Blotting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Normal β-globulin allele has __ DdeI restriction sites Patients with sickle cell only have __ restriction sites

A

3 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Normal human insulin has (1) at position 28 and (2) at position 29 at C terminus of B chain Lispro (Eli Lilly) (3) (4) Insulin aspart (Novo Nordisk) – (1) 28 replaced by (5)

A
  1. proline 2. lysine 3. lysine 4. proline 5. aspartic acid
102
Q

measures the amount of an antibody in a sample. measures the amount of an antigen in a sample.

A

indirect (ex. HIV) sandwich (ex. pregnancy test, MI)

103
Q

Cardiac forms of (1) and (2) increase in acute myocardial infarction

A
  1. T 2. I
104
Q

a molecule or part of a molecule that is recognized by the immune system. Loosely associated with adaptive response

A

antigen

105
Q

: an antigen that evokes a specific immune response

A

immunogen

106
Q

An antigen that induces immunologic tolerance

A

tolerogen

107
Q

tissue specific antigen, which is present in one individual of a species but not in others. Ex: ABO, HLA etc.

A

alloantigens

108
Q

Non-protein Ags, such as polysaccharides and lipids that can stimulate antibody responses without T help. Usually, multiple identical epitopes that can cross-link several BCRs.

A

T-independent antigens

109
Q

Immune responses against only a very few peptides that can be presented to T cells

A

immunodominant epitopes

110
Q

Small molecules which cannot induce an immune response alone. Inability to bind to MHC/HLA, cannot activate T cells Univalent, cannot activate B cells Do induce response when coupled with carrier protein

A

Haptens

111
Q

bind directly to HLA class II molecules and Vβ of the TCR. Activates a distinct set of Vβ-expressing T lymphocytes, depending on which Vβ gene segment the T lymphocyte is expressing.

A

Superantigens

112
Q

Fab, Fc

A

papain digestion

113
Q

F(ab’)2

A

pepsin digestion

114
Q

Allelic differences – H chains

A

allotype

115
Q

Antigenic determinants on the V regions

A

idiotype

116
Q

First antibody produced in primary response to antigen antigen produced by neonates Pentamer – 10 antigen-binding sites Efficient binding of Ags with multiple repeating epitopes Viruses, RBCs Efficient binding C’ (classical) “fixer” Expressed on B lymphocytes – as a monomer J piece Fc linked polypeptide disulfide-bonded to 2 of the 10 m chains Binds to secretory cells - mucosa

A

IgM

117
Q

Predominant Ab of secondary immune responses Most abundant class in serum 80% of total serum antibodies 4 subclasses

A

IgG

118
Q

Constituent of secondary immune responses Mucosal Immunity Predominant Ab class in external secretions: colostrum, saliva, tears, mucus Secretory component Polypeptide produced by epithelial cells of the mucous membranes – binds to Fc domains of IgA dimer Functional significance – Entry point for antigens Polymeric – efficiency Newborn immunity

A

IgA

119
Q

Constituent of secondary immune responses Low concentration in serum (0.05 µg/ml) Binds to blood basophils and tissue mast cells by Fc receptor with very high affinity. CD23a & CD23b (FceRI) Powerful pharmacologic reactions Actual function is protection against Helminth infections Asthma, allergies

A

IgE

120
Q

an Ag-specific receptor on mature B lymphocytes. Function not understood

A

IgD

121
Q

The strength of the interaction between an univalent Ag (epitope) & univalent Ab (paratope) is loosely referred to as

A

affinity

122
Q

The strength of the interaction between a multivalent Ag and a multivalent Ab is referred to as

A

avidity

123
Q

encoded by three separate gene regions in the MHC/HLA locus HLA-A HLA-B HLA-C Membrane bound glycoproteins Expressed on all nucleated cells Present antigen to CD8+ cytotoxic T-lymphocytes (CTL) Inhibitory receptor for NK cells

A

MHC I

124
Q

Describe MHC I synthesis

A
  1. Viral protein ubiquinated 2. Proteosome degrades protein to peptides 3.
125
Q

Encoded by the HLA-D region Three sets of genes alpha and beta chains HLA-DP HLA-DQ HLA-DR Membrane bound glycoproteins Primarily on antigen-presenting cells macrophages, dendritic cells and B-lymphocytes Presents antigen to CD4+ T-lymphocyte

A

MHC II

126
Q

Key features of MHC II

A

All alleles of the  and  chains are expressed 6  chains & 6  chains (3 from mom and 3 from dad) Any  chain allele may associate with any  chain allele Adds to the diversity of the peptide binding groove Greater range of peptides that can bind to Class II MHC/HLA Antigenic peptides and MHC/HLA association Saturatable, low affinity interaction Slow “on rate” Very slow “off rate” allow peptide-HLA complexes to persist long enough to interact with T-lymphocytes Only one peptide binds to a molecule of MHC/HLA at any one time class I or II Same molecule of MHC/HLA has the capacity to bind to multiple peptides not at the same time class I or II

127
Q

Ankylosing spondylitis Rheumatic fever Sjögren’s Syndrome Insulin-dependent diabetes mellitus Psoriasis

A
  1. HLA-B27 (inflammation of the spine) 2. HLA-DR4 (cardiac tissue) 3. HLA-DR3 (defect in salivation, lacrimation) 4. HLA-DQw8 5. HLA-B3
128
Q

Processing defects TAP down regulated

A
  1. Neuroblastoma 2. renal cell carcinoma
129
Q

TAP protein is nonfunctional, so peptides cannot enter the ER Symptoms: chronic respiratory infections, poor response to viruses

A

Bare lymphocyte syndrome

130
Q

an inherited defect in CIITA, leading to a deficiency in HLA class II expression on cells and non-functioning T lymphocytes. Reduced Th cell count due to failed thymic selection Reduced antigen presentation to mature CD4+ T cells Decreased Humoral and CMI responses, including DTH Patients have severe, recurrent infections

A

Bare Lymphocyte Syndrome Class II

131
Q

Histone protein amino acid residues

A

Lysine, Arginine

132
Q

Lightly packed form of chromatin- (DNA, RNA and protein) Highly enriched in genes Often (but not always) under active transcription Most active portion of the genome

A

Euchromatin

133
Q

very condensed chromatin: Stains darkly throughout the cell cycle, even in interphase Thought to be late replicating and genetically inactive Highly concentrated at centromeres and telomeres Contains very few active genes: Those that are present are resistant to gene expression

A

Heterochromatin

134
Q

unwinds DNA helix relieves supercoils binds single-stranded DNA that has been separated synthesizes DNA-RNA primer synthesizes new DNA strand 5-3 removes RNA primers fills in gaps seals nicks

A
  1. Helicase 2. Topoisomerase 3. Single-stranded DNA-binding protein 4. DNA polymerase alpha (primase) 5. DNA polymerase gamma, episolon 6. FEN1 7. DNA polymerase gamma 8. DNA ligase
135
Q

Block the cell cycle Generate single and double stranded breaks Harms the integrity of the genome Leads to apoptosis and cancer cell death

A

Topoisomerase inhibitors Irinotecan (I-colorectal) Etoposide, Doxorubicin (cardiotoxicity), Daunorubicin (cardiotoxicity) (II-leukemia)

136
Q

Ionizing radiation Non-ionizing radiation depurination deamination cross-linking

A
  1. strand breaks, thymine-tyrosine crosslinks 2. thymine dimers 3. A, G 4. A, G, C 5. BPDE, aflatoxin
137
Q

Cross-linking agents

A

nitrogen mustard cisplatin mitomycin C carmustine

138
Q

alkylating agents

A

dimethyl sulfate (DMS) methyl methanesulfonate (MMS)

139
Q

intercalating agents

A

Ethidium bromide thalidomide doxorubicin daunomycin

140
Q

Nucleotide excision repair

A

Xeroderma pigmentosum

141
Q

Mismatch excision repair

A

Hereditary nonpolyposis colorectal cancer MSH 2, 3 MLH1, PMS2

142
Q

Transcription coupled repair

A

Cockayne syndrome

143
Q

Homologous recombination

A

BRCA 1,2

144
Q

Ataxia telangiectasia

A

ATM, protein activated by double stranded breaks

145
Q

DNA interstrand cross-link repair

A

Fanconi anemia

146
Q

Base excision repair pathway

A
  1. DNA glycosylase removes altered base 2. AP endonuclease cleaves phosphodiester bond 3. AP lyase removes deoxyribose phosphate 4. DNA polymerase beta replaces nucleotide 5. DNA ligase seals nick
147
Q

Nucleotide excision repair pathway

A
  1. NER complex recognizes distortion, nicks both sides 2. DNA helicase removes strand 3. DNA polymerase episolon fills gap 4. DNA ligase seals nick
148
Q

Mismatch excision repair pathway

A
  1. Binding of mismatch repair protein 2. MutS binds altered base 3. MutL scans for nick, degrades strand 4. DNA polymerase gamma fills gap 5. DNA ligase seals nick
149
Q

Defect in transcription-coupled repair Growth retardation, skeletal abnormalities, sensitivity to sunlight RNA polymerase is permanently stalled at sites of damage in important genes

A

Cockayne syndrome

150
Q

HAT inhibitors

A

Garcinol Curcumin Anacardic acid

151
Q

HDAC inhibitors

A

Valproic acid Vorinostat

152
Q

Binds to the Beta subunit of bacterial RNA polymerase Unable to perform RNA translation

A

Rifampicin Side effects: upregulation of hepatic cytochrome p450 enzymes, red color to urine, sweat, tears

153
Q

segments of DNA on a chromosome one of two identical copies of a chromosome two identical chromosomes connects identical sister chromatids a region at the end of a chromosome for stability

A

Gene Chromatid Sister chromatids Centromere Teolomere

154
Q

Genetic variability of one gene Conversely, individuals with the same genotype can have multiple phenotypes

A

Pleiotropy (ex. PKU)

155
Q

Also called X-inactivation Females have two X chromosomes, so one is inactivated Which X chromosome is inactivated is random One copy of a gene is “turned off”

A

Lyonization

156
Q

Two or more populations of cells with different genotypes in an individual who has developed from a single fertilized egg

A

Mosaicism

157
Q

underproduction of hemoglobin cannot bind heme mutated hemoglobin (HgS) creates sickle-shaped RBCs

A

Thalassemia Methemoglobinemia Sickle cell disease

158
Q
  1. chromosome duplication, DNA duplicated 2. chromosomal condensation (X-shaped). Mitotic spindle forms between centriole 3. chromosomes align across the cell 4. sister chromatids pulled apart by centrioles to opposite poles 5. chromosomes gather at each pole, nucleal membrane forms. Cell divides
A

Interphase Prophase Metaphase Anaphase Telophase/Cytokinesis

159
Q

V(D)J recombinase is responsible for recombining V,D and J segments

A

RAG 1/2

160
Q

an insertion of a series of nucleotides which is catalyzed by the enzyme added to asymmetrically cleaved hairpins in a templated manner Added in a non- templated manner

A

terminal deoxyribonucleotidyl transferase (TdT) P nucleotides N nucleotides

161
Q

B-cell and stem cells initially interact through (1) and (2) on (3) Promotesanother interaction between the (4) and (5) leading to proliferation The cytokine (6) acts on B and T lymphocytes altering the expression of proteins required for development

A

1.VCAM-1 2.VLA -4 3.Stromal cells 4.stem cell factor (SCF) 5.Kit 6.IL -7

162
Q

assesses the compatibility of receptors produced from successive gene rearrangements Does NOT occur in T cells!

A

Receptor editing

163
Q

an individual T cell can express one β chain encoded by only one of the two inherited alleles. ensures that every T cell will express a single receptor, thus maintaining clonal specificity.

A

allelic exclusion

164
Q

thymocytes are self-MHC restricted, but they may still be able to react to self antigen

A

Positive selection

165
Q

Small population of self -reactive CD4+ T lymphocytes undergo differentiation to become (1) Function to inhibit self -reactive Th1 cells in the periphery Express both (2) and (3) on surface Unique transcription factor (4)

A
  1. Tregs 2. CD4 3. CD25 4. FoxP3
166
Q

Inactivation of: 1. C3b 2. C4b via cleavage

A
  1. Factor I, MCP, CR1, Factor H 2. Factor I, MCP, CR1, C4BP
167
Q

Inactivation of: 1. C3 convertase 2. C5 converstase via assembly inhibition

A
  1. DAF, CR1, Factor H 2. DAF, CR1, C4BP
168
Q

Inactivation of: MAC via assembly inhibition

A

CD59, vitronectin, S protein (clusterin)

169
Q

Inactivation of: C1r,s via dissociation

A

C1NH

170
Q

Inflammatory effects of soluble C3a

A

+: smooth muscle contraction, increased blood vessel permeability, degranulation of basophils -:chemotaxis, release 02 radicals, lysosome enzymes

171
Q

Inflammatory effects of soluble C5a

A

++++:smooth muscle contraction, increased blood vessel permeability, chemotaxis, release 02 radicals, lysosome enzymes +:degranulation of basophils,

172
Q

Inflammatory effects of soluble C5a

A

++++:smooth muscle contraction, increased blood vessel permeability, chemotaxis (neutrophils), release 02 radicals, lysosome enzymes +:degranulation of basophils,

173
Q

Complement in the Pathogenesis of Lupus Nephritis

A
  1. Formation of immune complexes 2. Deposition of immune complexes in glomeruli 3. Complement‐ and Fc receptor‐mediated activation of immune cells and chemotaxis 4. Production and release of pro‐inflammatory mediators (ROS, TNF-alpha, IFN-gamma) 5. Lession and tissue fibrosis
174
Q

Immune-Mediated Mechanisms of Vasculitis

A

Abs induced by the disease process bind Ags. interaction forms a immune complex (IC) that deposits within the vessel wall. Deposition of the ICs causes vasculitis through the classical pathway of complement activation. hepatitis B and hepatitis C infections and SLE, Drug‐induced vasculitis

175
Q

HEREDITARY ANGIOEDEMA (HAE)

A

very rare, genetic condition HAE SYMPTOMS include edema (swelling), abdominal pain, nausea, and vomiting, DEATH by ASPHYXIATION. C1 Inhibitor Deficiency. continuous activation of the plasma complement. In addition, C1‐INH inactivates plasma kallikrein, an enzyme that cleaves a plasma kininogen to produce bradykinin. BRADYKININ produced from kininogen is the cause of the swelling seen in HEA. Purified C1‐inhibitor replacement therapy

176
Q

Paroxysmal Nocturnal Hemoglobinuria (PNH)

A

SOMATIC MUTATION causes a deficiency of glycosylphosphatidylinositol. DAF,CD59 can’t bind to membrane most likely CAUSE of intravascular hemolysis therapy: monoclonal antibodies compstatin (C3) and eculizumab (C5)

177
Q

Amyloidosis

A

Inflammation (joint) Pro-inflammatory cytokines release Hepatic production of SAA protein Inadequate breakdown and/or excessive accumulation Accumulation of AA amyloid (beta pleats) renal biopsy (amyloid is pink, congo red stain=apple green appearnace, special serum AA stain=brown) symptoms: peripheral edema, protein in urine=foamy

178
Q

Causes of AA amyloidosis

A

Chronic inflammatory conditions: Rheumatologic disease Rheumatoid arthritis Inflammatory disease of the gastrointestinal tract Ulcerative colitis, Crohn’s disease Chronic infections Tuberculosis, AIDS Hematologic malignancies Hodgkin lymphoma Hereditary disorders Familial Mediterranean Fever (FMF)

179
Q

Cell Cycle Phases

A

G0-phase: quiescent, intact proliferation capacity, non-cycling G1-phase (Gap 1): duration between completion of cell division and initiation of DNA replication where cells start building cell mass S-phase (Synthesis):DNA replication G -phase (Gap 2): duration between completion of DNA replication and initiation of cell division M-phase: mitosis

180
Q

Space occupying lesions that may or may not be neoplasms relatively autonomous abnormal growth with abnormal gene regulation, 2 types: benign and malignant (→ cancer) Malignant neoplasm (can produce metastasis) Secondary growth of cancer at different - location from primary neoplasm

A

Tumors Neoplasm Cancer Metastasis

181
Q

Adenovirus

A

Types 2, 5, 12 No cancer Experimental cell line

182
Q

Hepadnavirus

A

Hepatitis B virus Hepatocellular carcinoma Aflatoxin, alcohol, smoking

183
Q

Herpes virus

A

Epstein-Barr virus 1. Burkitt’s Lymphoma-Malaria-EBV 2. EBV-associated malignancies in immunosuppressed-Immunodeficiency-Causative 3. Nasopharyngeal carcinoma-Nitrosamines,genetic-Causative 4. Hodgkin’s lymphoma 5. Gastric Carcinoma

184
Q

Herpes virus

A

KSHV (HSV80) 1. Kaposi’s sarcoma-AIDS-Causative 2. Castleman’s disease-Causative 3. Primary effusion lymphomas-Causative

185
Q

Flavivirus

A

Hepatitis C virus (HCV) Hepatocellular carcinoma-Aflatoxin-Causative

186
Q

Papillomavirus

A

HPV-16,18,31,33,39 Anogenital cancers, upper airway cancers-smoking, oral contraceptives-Causative

187
Q

Papillomavirus

A

HPV-5,8,17,20,47 Skin cancer-Genetic disorder,UV, immunosuppression

188
Q

Polyomavirus

A

MCV-merkel cell cancer-UV, immunosuppression BK-prostate preneoplastic lesions JC-Brain tumors SV40-mesotheliomas, brain tumors

189
Q

Retroviruses

A

HTLV-1-ATL-Genetic-Causative HTLV-2-no cancer

190
Q

Necrosis

A

Cell membrane: Swelling and rupture. Cytoplasm: Increased vacuolation, organelle degeneration, and mitochondrial swelling. Nucleus : Clumping and random degradation of nuclear chromatin and DNA (karyolysis) Cells involved: All cell types. Inflammation: Yes. Biochemical features: Extensive failure of normal physiological pathways that are essential for maintaining cellular homeostasis, such as regulation of ion transport, energy production (ATP Depletion) and pH balance.

191
Q

Apoptosis

A

Cell membrane: membrane blebbing and eventually fragmentation into membrane bound apoptotic bodies. Cytoplasm: Fragmentation and shrinkage Nucleus : Chromatin condensation and degradation via specific DNA cleavage leading to nuclear fragmentation. Cells involved: hematopoietic cells and their malignant counterparts (liquid tumors). Apoptosis only plays a modest role in the treatment response of most solid tumors, which constitute the major part of human malignancies. Inflammation: No. Biochemical features: Cell membrane loses its asymmetry, and phosphatidylserine becomes exposed on the cell surface (eat me signal). Caspase (protease)/Mitochondria –dependent.

192
Q

Autophagy

A

Cell membrane: membrane blebbing Cytoplasm: accumulation of two-membrane autophagic vacuoles. Nucleus : Partial chromatin condensation No nuclear and DNA fragmentation. Cells involved: All cell types Inflammation: No. Biochemical features: Caspase-independent and increased lysosomal activity.

193
Q

Mitotic catastrophe

A

Cell membrane: No change Cytoplasm: larger cytoplasm with the formation of giant cell. Nucleus : micronucleation and multinucleation, nuclear fragmentation. Premature chromosome condensation. formation of nuclear envelopes around individual clusters of missegregated chromosomes Cells involved: Most dividing cells Inflammation: No. Biochemical features: Caspase-independent (at early stage). abnormal CDK1/cyclin B activation

194
Q

Senescence

A

Cell membrane: No change Cytoplasm: Flattening and increased granularity. Nucleus : Distinct heterochromatic structure Cells involved: All types of cells Inflammation: Yes but induced by secretory factors from the senescent cell it self.

195
Q

capable of denaturing certain macromolecules such as DNA macromolecules cross-linking agents

A

Alkylating agents Cyclophosphamide Ifosfamide Meclorethamine Chlorambucil Melphalan Lomustine Thiotepa Dacarbacine (DTIC)

196
Q

which interact with DNA and are intercalated between two bases, inducing a structural change and a functioning of this molecule– cleaving agents, capable of breaking DNA molecules.

A

Antitumor-intercalating Doxorubicin Actinomycin D Mitoxantrone Bleomycin

197
Q

that can be structural analogues of purines or pyrimidines; they block the synthesis of the corresponding bases (5 FU), or folate analogues.

A

Antimetabolites Cytosine – arabinoside 5-Fluorouracil Methotrexate Vincristine Vinblastine

198
Q

that inhibit tubulin synthesis, these being cell spindle poisons

A

Mitostatic agents L-Asparaginase

199
Q

which plays a role by DNA binding

A

Platinum derivatives Platinum bonds (Cisplatin, Carboplatin) Hydroxyurea Taxol

200
Q

TLR1/2 TLR2/6 TLR3 TLR4/4 TLR5 TLR7 TLR8 TLR9

A

TLR1/2: bacteria/parasites (Lipopeptides,GPI), plasma TLR2/6: Gram+/fungi (Lipoteichoic acid), plasma TLR3: double-stranded RNA, West Nile, NK, endosome TLR4/4: Gram-, plasma TLR5: motile flagella, plasma TLR7: ssRNA, HIV, endosome TLR8: ssRNA, Influenza, NK, endosome TLR9: unmethylated CpG, Herpes, endosome

201
Q

DAMPs Activate NF-kB

A

HMGB1: TLR2/3 Uric acid: NLPR3 HSP: TLR2/4 activate NFK-beta->TNF-alpha, IL-1

202
Q

Timing of Mast Cell Activation

A

Seconds: Proteases, TNF, histamine Minutes: Eicosinoids, Prostaglandins, Leukotrienes Hours: TNF, IL-4

203
Q

Cells that produce TNF

A

Macrophages T cells Mast cells

204
Q

Cells that produce IL-1

A

Macrophages Dendritic cells Endothelial cells Mast cells Epithelial cells

205
Q

Cells that produce Chemokines

A

Macrophages Dendritic cells Endothelial cells T lymphocytes Fibroblasts Platelets

206
Q

Cells that produce IL-12

A

Macrophages Dendritic cells

207
Q

Cells that produce Interferon-gamma

A

NK cells T lymphocytes

208
Q

Cells that produce IFN-alpha

A

Macrophages Dendritic cells

209
Q

Cells that produce IFN-beta

A

Fibroblasts

210
Q

Cells that produce IL-10

A

Macrophages Dendritic cells T cells

211
Q

Cells that produce IL-6

A

Macrophages Endothelial cells T cells

212
Q

Cells that produce IL-15/IL-18

A

Macrophages

213
Q

Cells that produce TGF-beta

A

Macrophages

214
Q

TNF

A

Endothelial cells: activation Neutrophil: activation Hypothalamus: fever Liver: synthesis of acute-phase proteins Muscle/fat: catabolism (cachexia) Cells: apoptosis

215
Q

IL-1

A

Endothelial cells: activation Hypothalamus: fever Liver: synthesis of acute phase proteins T cells: Th17 differentation

216
Q

Chemokines

A

Leukocytes: increased integrin activity, chemotaxis, activation

217
Q

IL-12

A

NK/T cell: IFN-gamma production, cytotoxicity T cell: Th1 differentiation

218
Q

IFN-gamma

A

Macrophage: activation Stimulation of antibody response

219
Q

IFN-alpha

A

All cells: antiviral, MHC I expression NK: activation

220
Q

IFN-beta

A

All cells: antiviral, MHC I expression NK: activation

221
Q

IL-10

A

Macrophages/DC: inhibit cytokine/chemokine production, decrease costimulator and MHC II production

222
Q

IL-6

A

Liver: synthesis of acute-phase proteins B cells: proliferate antibody-producing cells

223
Q

IL-15

A

NK/T cell: proliferation

224
Q

IL-18

A

NK/T cells: IFN-gamma production

225
Q

TGF-Beta

A

Inhibition of inflammation T cells: differentiate into Th17, regulatory T cells

226
Q

Neutrophil Recruitment Cascade

A

TNF-alpha, IL-1 from macrophage Neutrophil: ESL-1, PSGL-1, LFA-1, VLA-4 (IL-8=activation) Endothelial cell: E-selectin, P-selectin, ICAM-1, VCAM-1

227
Q

M1 M2

A

M1: activation (TLR-ligand, IFN-gamma) M1: secretion (ROS, NO, lysosomal, IL-1, IL-12, IL-23) M2: activation (IL-4, IL-13) M2 secretion (IL-10, TGF-beta)

228
Q

Sometimes the result of specific memory is that re-exposure to the same stimulus, as well as or instead of eliminating the stimulus, has unpleasant or damaging effects on the body’s own tissues

A

Hypersensitivity

229
Q

Autoimmunity, hypersensitivity and, above all, transplant rejection sometimes necessitate the suppression of adaptive immune responses by drugs or other means.

A

Immunosuppression

230
Q

The body’s own cells and molecules do not normally stimulate its adaptive immune responses because of a variety of special mechanisms that ensure a state of self-tolerance, but in certain circumstances they do stimulate a response and the body’s own structures are attacked as if they were foreig

A

Autoimmunity

231
Q
A

autosomal dominant

232
Q
A

Autosomal recessive

233
Q
A

mitochondrial inheritance

234
Q

MHC Class II Presentation

A
235
Q

MHC Class I Presentation

A
236
Q

B lymphocyte Development

A
237
Q

T lymphocyte development

A
238
Q

G1/S Transition

A
239
Q

During S Phase

A
240
Q

G2/M Transition

A
241
Q

G1 Checkpoint

A
242
Q

G1 Checkpoint Part II

A
243
Q

G2 Checkpoint

A
244
Q

Necrosis mechanism

A
245
Q

Apoptosis mechanism

A
246
Q

Senescence mechanism

A
247
Q

Classical Complement Pathway

A
248
Q

Alternative Complement Pathway

A
249
Q

Lectin Complement Pathway

A
250
Q

Osmosis lecture formula for osmolarity

A

2*(Na+2 concentration)+ (glucose/14.8) + (BUN/4.5)

SFM Final (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions